Christophe Deben
Wilrijk, VLG 2610, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 51 publications
IL-15 boosts mesothelin- and CD70-CAR NK cell potency in PDAC without added benefit from dual targeting.
Journal: Molecular therapy. Oncology
Published: May 08, 2026
Forecasting a clear vision: How QSAR modeling catalyzes small molecule discovery in the field of corneal endothelial regeneration.
Journal: SLAS discovery : advancing life sciences R & D
Published: April 06, 2026
DRP1 depletion protects NK cells from hypoxia-induced dysfunction.
Journal: Redox report : communications in free radical research
Published: February 18, 2026
In vitro and in silico modelling of ROS1-positive non-small cell lung cancer reveals fusion-dependent tyrosine kinase inhibitor responses.
Journal: Molecular oncology
Published: September 23, 2025
Short cold atmospheric plasma treatment preserves vascular quiescence in 3D tumor-stroma-endothelial models of pancreatic cancer in vitro and in ovo.
Journal: NPJ precision oncology
Published: May 26, 2025
Capturing the Heterogeneity of the PDAC Tumor Microenvironment: Novel Triple Co-Culture Spheroids for Drug Screening and Angiogenic Evaluation.
Journal: Cells
Published: February 14, 2025
STING Agonists and How to Reach Their Full Potential in Cancer Immunotherapy.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: January 06, 2025
"Keep on ROCKIn": Repurposed ROCK inhibitors to boost corneal endothelial regeneration.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: January 10, 2024
Auranofin repurposing for lung and pancreatic cancer: low CA12 expression as a marker of sensitivity in patient-derived organoids, with potentiated efficacy by AKT inhibition.
Journal: Journal of experimental & clinical cancer research : CR
Published: January 02, 2024
Last Updated: 09/26/2026